Your browser doesn't support javascript.
loading
Evaluation of palonosetron, fosaprepitant, and olanzapine as antiemetic prophylaxis for fludarabine and melphalan-based conditioning regimens prior to allogeneic hematopoietic stem cell transplants.
Karpen, Riley; Sen, Jeremy; Wall, Sarah; Musson, Samantha; Tossey, Justin.
Afiliación
  • Karpen R; Department of Pharmacy, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, 460 West 10th Avenue, Columbus, OH, USA.
  • Sen J; Department of Pharmacy, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, 460 West 10th Avenue, Columbus, OH, USA.
  • Wall S; Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, 460 West 10th Avenue, Columbus, OH, USA.
  • Musson S; Department of Pharmacy, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, 460 West 10th Avenue, Columbus, OH, USA.
  • Tossey J; Department of Pharmacy, The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, 460 West 10th Avenue, Columbus, OH, USA. Electronic address: justin.tossey@osumc.edu.
Leuk Res ; 136: 107431, 2024 01.
Article en En | MEDLINE | ID: mdl-38043326

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vidarabina / Morfolinas / Trasplante de Células Madre Hematopoyéticas / Antieméticos Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vidarabina / Morfolinas / Trasplante de Células Madre Hematopoyéticas / Antieméticos Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article